Hearscape
← Organizations
Sponsor / Institution

Hadassah Medical Center

Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.

All ProgramsTherapeuticsDevices
Open filtered programs
Programs
1
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
1
0 open data checks
Company / Institution Links
0 / 1
industry vs non-industry records
Competitive Density
3
Pipeline Velocity
0
Completion Signal
0

Programs by Stage

Phase 21

Trial / Program Status

Unknown1

Modality Mix

Small Molecule1

Indication Coverage

Genetic Hearing Loss1
Hearing Loss1
Sensorineural Hearing Loss1
Wolfram Syndrome1

Program Types

Therapeutic1

Population Tags

adult1
genetic1
pediatric1
syndromic1

Strong-Evidence Records

0 records
No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

1 checked · 0 open checks
Hadassah Wolfram Syndrome Type 2 Combination Therapy Study
Details checked
Small MoleculePhase 2Unknown

Academic Phase 2 study evaluating a combination strategy for genetically diagnosed Wolfram syndrome type 2: deferiprone chelation plus acetylcysteine antioxidant therapy, with sitagliptin/metformin added for participants with diabetes. The component drugs are trial arms/components, not separate industry-sponsored hearing-loss pipeline programs.

Data checks: institution-led-study, merged-generated-intervention-arms